China Resources Pharmaceutical Group Limited

Research China Resources Pharmaceutical Group Limited (640) on Bullrun: market cap EUR 2.97B, P/E 5.9, dividend yield 5.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• Ticker640
• ExchangeF
• CountryHong Kong
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 2.97B
• P/E5.9
• Dividend yield5.1%
• Financial periodFY2025
• RevenueEUR 269.57B
• Revenue growth4.6%
• Net incomeEUR 4.05B
• Free cash flowEUR 16.93B
• Gross margin16.5%

Valuation Snapshot

latest market cap is EUR 2.97B; P/E is 5.9; dividend yield is 5.1%.

About China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others.

Frequently asked questions

What is China Resources Pharmaceutical Group Limited's market cap?

China Resources Pharmaceutical Group Limited's market capitalization is EUR 2.97B.

What is China Resources Pharmaceutical Group Limited's P/E ratio?

China Resources Pharmaceutical Group Limited's price-to-earnings (P/E) ratio is 5.9.

Does China Resources Pharmaceutical Group Limited pay a dividend?

China Resources Pharmaceutical Group Limited has a dividend yield of 5.1%.

What does China Resources Pharmaceutical Group Limited do?

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.